Mirae Asset Global ETFs Holdings
TVRD

Mirae Asset Global ETFs Holdings’s Tvardi Therapeutics TVRD Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.49K Buy
2,356
+68
+3% +$266 ﹤0.01% 3084
2025
Q4 		$9.84K Buy
2,288
+88
+4% +$789 ﹤0.01% 3079
2025
Q3 		$85.7K Buy
2,200
+337
+18% +$9.6K ﹤0.01% 2731
2025
Q2 		$43.5K Buy
+1,863
New +$44.1K ﹤0.01% 2908
2024
Q3 		– Sell
-678
Closed -$6.3K – 3210
2024
Q2 		$6.3K Buy
+678
New +$16.2K ﹤0.01% 2974

Other funds holding TVRD

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DWAM
Duncan Williams Asset Management Memphis, Tennessee $444M AUM 24.78% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's TVRD Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Tvardi Therapeutics (TVRD) stake by 3% in Q1 2026, buying an estimated $266 and bringing the position to 2,356 shares worth $7.49K. The position accounts for ﹤0.01% of the portfolio, ranked #3084.

Mirae Asset Global ETFs Holdings first reported a position in TVRD in Q2 2024 and has held it in 5 quarters since. The position peaked at $85.7K in Q3 2025. 67 funds tracked by Wall St. Rank hold TVRD as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 2,356 shares of Tvardi Therapeutics worth $7.49K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 68 Tvardi Therapeutics shares in Q1 2026, an estimated $266.
  • Tvardi Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #3084 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Tvardi Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • Mirae Asset Global ETFs Holdings's Tvardi Therapeutics position peaked at $85.7K in Q3 2025.
  • 67 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.